1. Bělohlávek J., Dytrych V., Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp. Clin. Cardiol. 2013; 18 (2): 129-138.
2. Torbicki A., Perrier A., Konstantinides S. et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur. Heart J. 2008; 29 (18): 2276-2315. https://doi.org/10.1093/eurheartj/ehn310.
3. Rosovsky R.P., Grodzin C., Channick R. et al. Diagnosis and treatment of pulmonary embolism during the coronavirus disease 2019 pandemic: A Position Paper from the National PERT Consortium. Chest. 2020; 158 (6): 2590-2601. https://doi.org/10.1016/j.chest.2020.08.2064.
4. Sakr Y., Giovini M., Leone M. et al. Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A narrative review. Ann. Intensive Care. 2020; 10: 124. https://doi.org/10.1186/s13613-020-00741-0.
5. Malas M.B., Naazie I.N., Elsayed N. et al. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine. 2020; 29: 100639. https://doi.org/10.1016/j.eclinm.2020.100639.
6. Porfidia A., Valeriani E., Pola R. et al. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thromb. Res. 2020; 196: 67-74. https://doi.org/10.1016/j.thromres.2020.08.020.
7. Kanso M., Cardi T., Marzak H. et al. Delayed pulmonary embolism after COVID-19 pneumonia: a case report. Eur. Heart J. Case Rep. 2020; 4 (6):1-4. https://doi.org/10.1093/ehjcr/ytaa449.
8. Vechi H.T., Maia L.R., Alves M.D.M. Late acute pulmonary embolism after mild coronavirus disease 2019 (COVID-19): a case series. Rev. Inst. Med. Trop. Sao Paulo. 2020; 62: e63. https://doi.org/10.1590/S1678-9946202062063.
9. Fox S.E., Akmatbekov A., Harbert J.L. et al. Pulmonary and cardiac pathology in COVID-19: The first autopsy series from New Orleans. MedRxiv. [Preprint. Posted: April 10, 2020]. https://doi.org/10.1101/2020.04.06.20050575.
10. Lax S.F., Skok K., Zechner P. et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: Results from a prospective, single-center, clinicopathologic case series. Ann. Intern. Med. 2020; 173 (5): 350-361. https://doi.org/10.7326/M20-2566.
11. Ahmed S., Zimba O., Gasparyan A.Y. Thrombosis in coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad. Clin. Rheumatol. 2020; 39 (9): 2529-2543. https://doi.org/10.1007/s10067-020-05275-1.
12. Hunt B., Retter A., McClintock C. Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19. 25th March, 2020. Available at: https://b-s-h.org.uk/media/18171/thand-covid-25-march-2020-final.pdf [Accessed: December 25, 2020].
13. Галстян Г.М. Коагулопатия при COVID-19. Пульмонология. 2020; 30 (5): 645-657. https://doi.org/10.18093/0869-0189-2020-30-5-645-657.
14. Eljilany I., Elzouki A.N. D-dimer, fibrinogen, and IL-6 in COVID-19 patients with suspected venous thromboembolism: a narrative review. Vasc. Health Risk Manag. 2020; 16: 455-462. https://doi.org/10.2147/VHRM.S280962.
15. Di Tano G., Moschini L., Loffi M. et al. Late pulmonary embolism after COVID-19 pneumonia despite adequate rivaroxaban treatment. Eur. J. Case Rep. Intern. Med. 2020; 7 (7): 001790. https://doi.org/10.12890/2020_001790.